You can buy or sell Elanco and other stocks, options, ETFs, and crypto commission-free!
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. Read More The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.
52 Week High
52 Week Low
Meat Fish Dairy
Yahoo FinanceMay 9
Elanco Animal Health Incorporated Q1 2019 Earnings Call Transcript
Image source: The Motley Fool. Elanco Animal Health Inc. (NYSE: ELAN) Q1 2019 Earnings Call May 9, 2019, 8:00 a.m. ET Operator Good morning and welcome. My name is Susanne and I'll be your conference operator today. At this time, I would like to welcome everyone to the Elanco Animal Health Q1 2019 Earning Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. If you would like to ask a question durin...
Seeking AlphaMay 8
Elanco Q1 2019 Earnings Preview
Elanco (NYSE:ELAN) is scheduled to announce Q1 earnings results on Thursday, May 9th, before market open. The consensus EPS Estimate is $0.23 and the consensus Revenue Estimate is $743.71M Over the last 3 months, EPS estimates have seen 4 upward revisions and 2 downward. Revenue estimates have seen 3 upward revisions and 2 downward....
Expected Aug 13, Pre-Market